Sumitomo (SHI) Demag
Is this your company? Claim this profile
Manufacturing & Lab Equipment
Company Overview
About
Sumitomo (SHI) Demag is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Germany
Founded:1994
Employees:292
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval ZDXIMA
EMA · #APR-RF4W0UYB · 2019-06-01
Drug Approval ZZV7R7
EMA · #APR-P98SWXJO · 2022-07-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-MLHL0K4Q
Issued: 2020-06-11
Expires: 2025-07-14
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-FWNMFJV4
Issued: 2020-07-03
Expires: 2025-07-19
Loading CDMO intelligence...
Key facts about Sumitomo (SHI) Demag
- Sumitomo (SHI) Demag is headquartered in Germany.
- Sumitomo (SHI) Demag was founded in 1994.
- Sumitomo (SHI) Demag has 292 employees.
- Sumitomo (SHI) Demag's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Sumitomo (SHI) Demag
Directory pages this company appears in, each with the full list of matching manufacturers.